Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Select a linked metric to explore its chart.
SomnoMed Limited is a healthcare equipment company specializing in the development and commercialization of oral devices for the treatment of sleep-related breathing disorders. The company's core product range includes the SomnoDent line, a series of mandibular advancement devices designed for the management of obstructive sleep apnea, snoring, and bruxism. SomnoMed’s product portfolio comprises both signature and standard line devices, such as Avant, Herbst Advance Elite, Flex, and Classic, along with custom fit dental guards like the SomnoBrux, catering to different patient and clinician needs worldwide. Founded in 1987 and headquartered in Crows Nest, Australia, SomnoMed operates across the Asia Pacific, North America, and Europe, providing solutions that bridge medical and dental industries. The company serves a critical role in non-invasive sleep disorder management, offering alternatives to traditional treatments such as CPAP machines. Its products target a growing global health concern—sleep apnea—emphasizing patient comfort and compliance. SomnoMed is recognized within the healthcare sector for its innovation in oral appliance therapy and commands significant attention among practitioners seeking effective sleep disorder interventions.